Cargando…
Bacillus subtilis HU58 and Bacillus coagulans SC208 Probiotics Reduced the Effects of Antibiotic-Induced Gut Microbiome Dysbiosis in an M-SHIME(®) Model
Benefits associated with probiotic use have been reported; however, the mechanisms behind these benefits are poorly understood. The effects of a probiotic formulation (MegaDuo™) containing Bacillus coagulans SC208 and Bacillus subtilis HU58 on intestinal permeability and immune markers was assessed...
Autores principales: | Marzorati, Massimo, Van den Abbeele, Pieter, Bubeck, Sarah S., Bayne, Thomas, Krishnan, Kiran, Young, Aicacia, Mehta, Dilip, DeSouza, Anselm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409217/ https://www.ncbi.nlm.nih.gov/pubmed/32664604 http://dx.doi.org/10.3390/microorganisms8071028 |
Ejemplares similares
-
An Oral Formulation of the Probiotic, Bacillus subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy
por: Yossef, Sayed, et al.
Publicado: (2020) -
Long-Term Lactulose Administration Improves Dysbiosis Induced by Antibiotic and C. difficile in the PathoGut(TM) SHIME Model
por: Calatayud, Marta, et al.
Publicado: (2022) -
The effects of supplementation of Bacillus subtilis and Bacillus coagulans spores on the intestinal microflora and growth performance in rat
por: Mazkour, Somaye, et al.
Publicado: (2019) -
Complete Genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, Two Phylogenetically Distinct Probiotics
por: Khatri, Indu, et al.
Publicado: (2016) -
Safety and efficacy of Probion forte(®) (Bacillus subtilis
KCCM 10941P and Bacillus coagulans
KCCM 11093P) for chickens for fattening
por: Bampidis, Vasileios, et al.
Publicado: (2019)